New article for RSS

Proin vestibulum felis vel fringilla viverra. Sed efficitur laoreet massa, sit amet luctus orci sollicitudin sit amet. Donec suscipit placerat nulla, ut mattis nunc placerat et. Nullam porta nisl lorem, vitae euismod lacus semper eget.

Summary for the RSS

Sed ultrices nunc elit, eget euismod lectus pellentesque ac. Pellentesque maximus sem magna, in iaculis arcu maximus id. Quisque tellus justo, commodo non ipsum et, rutrum ultricies massa. Proin vestibulum felis vel fringilla viverra. Sed efficitur laoreet massa, sit amet luctus orci sollicitudin sit amet. Donec suscipit placerat nulla, ut mattis nunc placerat et. Nullam porta nisl lorem, vitae euismod lacus semper eget. Etiam eu dictum lorem. Nullam aliquet mi ut dolor pharetra auctor. Phasellus commodo, mi quis vulputate imperdiet, leo mi suscipit tellus, ut posuere nisi eros sit amet magna. Quisque et euismod diam. Sed magna arcu, volutpat at porttitor vitae, porttitor eget tortor. Donec non mi euismod, lobortis ipsum fermentum, scelerisque metus. Pellentesque consectetur faucibus blandit. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Ut eget feugiat augue.


Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Medtech Insight

Nancy Tests Infogram PDf Again

 

test description

Iran Deal In Place, But API Prices Stay Elevated And Pharma Supply Chains Face A Slow Recovery

A framework to end the Iran war is in place but fractured supply chains can’t recover overnight. Data from India suggests solvent prices have generally cooled from April peaks, but API costs stay elevated or even climbed in June for some products.

Bleep Bloop Blood: Vitestro’s Automated Blood-Drawing Robot Cleared For EU Market - Clone1

 

Vitestro's automated blood drawing robot received CE marking on August 28. The company is limiting release of the robot over the next 12 months to a small number of selected hospitals, with plans to scale up production thereafter.

Test Focus Of Tariff Conversations Shifts To Stability, AdvaMed Says - Clone - Clone

 
• By 

AdvaMed president Scott Whitaker said the group is focused on the need for tariff stability in conversations with the Trump administration. The organization remains optimistic about other policy areas. New chairman and ResMed CEO Mick Farrell laid out his five priorities.

More from Digital Technologies

Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances

 

The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.

News We’re Watching: Neuralink’s Blindsight Gets FDA Breakthrough Device Tag; FDA Pump Recalls, Guidances; Discure, DeepLook Bolster Coffers

This week, Neuralink announced it received US FDA breakthrough device designation for a device to restore sight; medtechs Discure and DeepLook secured new funding; FDA pump recalls from B. Braun Medical and Fresenius Kabi; Axonics prevails in patent infringement lawsuit with Medtronic; Merit Medical buys Cook Medical for $210m.

EU Launches Call For Regulatory Sandbox Initiative To Accelerate Medtech Innovation

 

The EU IHI’s eighth call for action also encourages innovative medtech approaches to tackling cardiovascular disease and osteoarthritis and patient-centered endpoints that can benefit from advancements in digital health.